AIDs continues to represent a critical issue for society. Despite significant developments on many fronts, the somber morbidity and mortality statistics remain. Intravenous drug abusers (IVDAs) comprise the second largest risk group and play a significant role in the prevalence of AIDS among adult females, heterosexuals, the pediatric age group, ethnic/racial minorities and New Yorkers. While drug abuse treatment has been advance as an HIV prevention strategy, many areas of difficulty exists in the delivery of drug treatment today. Concerned about the implications this holds for the nearly 2,100 patients under its care, the Addiction Research and Treatment Corporation (ARTC) proposes to establish a Treatment Research Unit (TRU) with a five year plan: 1. To increase enrollment in drug treatment of 300 persons dependent upon psychoactive substances that are associated with parenteral routes of administration or that are associated with disinhibiting behaviors that place these persons at risk of HIV infection; 2. To evaluate the efficacy of various pharmacologic and non- pharmacologic interventions that will reduce drug/sex behaviors associated with HIV transmission of HIV disease progression among persons enrolled in drug treatment; and 3. To identify factors (demographic, behavioral, and biomedical) associated with the success of various interventions to reduce HIV-associated transmission behaviors. Both survey/epidemiologic and ethnographic methods will be utilized to evaluate pharmacologic protocols, acupuncture, clinically guided self help and primary medical care study designs. The major theme of this Treatment Research Center (TRU) is the investigation of methods to improve methadone maintenance treatment. During the life of this TRU, flexibility will allow the examination of not only what interventions work and do not work, but also help explain why some approaches work in some circumstances and not in others.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Demonstration and Dissemination Projects (R18)
Project #
5R18DA006142-03
Application #
3441666
Study Section
Special Emphasis Panel (SRCD (01))
Project Start
1989-09-30
Project End
1994-08-31
Budget Start
1991-09-30
Budget End
1992-08-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Addiction Research and Treatment Corp
Department
Type
DUNS #
078170883
City
New York
State
NY
Country
United States
Zip Code
11201
Mogil, J S; Pasternak, G W (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53:381-415
Meyer, T J; Lin, M M; Brown Jr, L S (1996) Nicotine dependence and depression among methadone maintenance patients. J Natl Med Assoc 88:800-4
Brown, L S; Sawyer, R C; Li, R et al. (1996) Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users. Drug Alcohol Depend 43:71-7
Villagomez, R E; Meyer, T J; Lin, M M et al. (1995) Post-traumatic stress disorder among inner city methadone maintenance patients. J Subst Abuse Treat 12:253-7
Brown Jr, L S (1993) Alcohol abuse prevention in African-American communities. J Natl Med Assoc 85:665-73
Brown Jr, L S (1993) Enrollment of drug abusers in HIV clinical trials: a public health imperative for communities of color. J Psychoactive Drugs 25:45-52
Brown Jr, L S; Singer, F; Killian, P (1991) Endocrine complications of AIDS and drug addiction. Endocrinol Metab Clin North Am 20:655-73